Stock Exchange Announcement And Disclosures - Sanofi in India

2024

STOCK EXCHANGE ANNOUNCEMENT AND DISCLOSURES 2024

Intimation for Closure of Trading Window (PDF • 2024)

Resignation of Senior Management Personnel (2024) (PDF • 2024)

Clarification on appointment of Independent Directors by Sanofi Consumer Healthcare India Limited (PDF • 2024)

Appointment of Independent Directors by Sanofi Consumer Healthcare India Limited (PDF • 2024)

2023

STOCK EXCHANGE ANNOUNCEMENT AND DISCLOSURES 2023

Intimation for Closure of Trading Window (PDF • Sept 2023)

Change in Directorate (PDF • Sept 2023)

Intimation for Closure of Trading Window (PDF • Sept 2023)

Investor / Analyst Meet Transcript 11.05.2023 (PDF • May 2023)

Communication Of Deduction Of Tax At Source On Dividend (PDF • April 2023)

Announcement Under Regulation 30 - NLEM Communication (PDF • April 2023)

Recording of Investor / Analyst Call - May 2023

Recording of Investor / Analyst Call - Feb 2023

2022

STOCK EXCHANGE ANNOUNCEMENT AND DISCLOSURES 2022

Intimation of Closure of Trading Window (PDF • December 23 2022)

Intimation of Closure of Trading Window (PDF • September 2022)

Board approves One Time Special Interim Dividend (PDF • 2022-07-26)

Interim Dividend and Record Date (PDF • 2022-07-13)

Intimation of Closure of Trading Window (PDF • June 27 2022)

Intimation of Closure of Trading Window (PDF • March 28 2022)

Secretarial Compliance Report for year ended 31st December 2021 (PDF • 2022-03-08)

Re-appointment of Statutory Auditors (PDF • 2022-02-23)

Dividend, AGM Date & Book Closure Date (PDF • 2022-02-23)

Update on Divestment of Soframycin® and Sofradex® businesses – Completion of the Transaction (PDF • 2022-01-31)

2021

STOCK EXCHANGE ANNOUNCEMENT AND DISCLOSURES 2021

Slump Sale and transfer of the Nutraceuticals business of the Company (PDF • September 30, 2021)

AGM and E-voting Publication (PDF • April 01, 2021)

AGM through Video Conferencing Facility (PDF • March 16, 2021)

Appointment / Re-appointment of Directors, Re-appointment of Chairman (PDF • February 24, 2021)

Final Dividend, AGM & Book Closure (PDF • February 24, 2021)

Proposed divestment of Soframycin® and Sofradex® businesses (PDF • February 05, 2021)

2020

STOCK EXCHANGE ANNOUNCEMENT AND DISCLOSURES 2020

Appointment of Directors (PDF • July 28, 2020)

Press Release - Sanofi India Launches ‘Allergy Free’ (PDF • June 30, 2020)

AGM & E-voting Publication (PDF • June 12, 2020)

Closing of Transaction - Transfer of Ankleshwar Site to Zentiva (PDF • May 29, 2020)

AGM through Video Conferencing Facility (PDF • May 28, 2020)

AGM, Book Closure and Dividend Payment Date (PDF • May 19, 2020)

Cessation of the term as Independent Director – Mr. Rangaswamy R. Iyer (PDF • March 31, 2020)

Change in Closing date for transaction related to Slump Sale and transfer of Manufacturing Facility at Ankleshwar (PDF • March 27, 2020)

Change in Annual General Meeting (AGM) Date & Book Closure Date (PDF • March 23, 2020)

Final Dividend, AGM & Book Closure (PDF • February 25, 2020)

Resignation of Non Executive Directors (PDF • February 25, 2020)

2019

STOCK EXCHANGE ANNOUNCEMENT AND DISCLOSURES 2019

Sanofi India Limited to sell Ankleshwar site to Zentiva (PDF • September 11, 2019)

Appointment of Additional Director and Whole Time Director (PDF • July 29, 2019)

AGM & E-Voting Publication (PDF • April 11, 2019)

Directorate of Health Services (Government of Goa) and Sanofi India join hands to reduce diabetes burden on the State’s health exchequer (PDF • February 1, 2019)

Combiflam® ICYHOT™ takes on ‘strong pain’ in its new ad campaign created by Ogilvy (PDF • January 21, 2019)

2018

STOCK EXCHANGE ANNOUNCEMENT AND DISCLOSURES 2018

Press Release - Combiflam® Range of Pain Relief Solutions introduces Pain Education Campaign in Bihar (PDF • October 10, 2018)

26 young people with type 1 diabetes successfully surmount 13,000 ft., in ‘India’s 2nd T1D Challenge 2018’ (PDF • September 18, 2018)

Resignation of Non – Executive Director (PDF • July 25, 2018)

Interim Dividend 2018 & Record Date (PDF • July 25, 2018)

Appointment of Additional Director and Whole Time Director (PDF • July 25, 2018)

Board to Consider Interim Dividend on 25th July 2018 (PDF • July 19, 2018)

Press Release - Combiflam® Range of Pain Relief Solutions launches Pain Education Campaign (PDF • July 11, 2018)

AGM & E-voting Publication (PDF • April 11, 2018)

Notice of AGM to be held on 08.05.2018 (PDF • April 10, 2018)

Final Dividend, AGM & Book Closure (PDF • February 22, 2018)

Sanofi launches new insulin Toujeo ™ in India (PDF • February 12, 2018)

Resignation of Independent Director (PDF • January 15, 2018)

Authorized officials for disclosure of material information to Stock Exchanges (PDF • January 15, 2018)

2017

STOCK EXCHANGE ANNOUNCEMENT AND DISCLOSURES 2017

Sanofi India Limited appoints N. Rajaram as Managing Director (PDF • December 15, 2017)

Re-organization of the Board (PDF • December 15, 2017)

Sanofi Launches ‘Combiflam® ICYHOT™’ Pain Relief Topical in India - 11.09.2017 (PDF • September 11, 2017)

Publication of Record date (PDF • July 21, 2017)

Declaration of Dividend and Record Date (PDF • July 19, 2017)

AGM Publication - 08.04.2017 (PDF • April 10, 2017)

Clarification on News Article www.reuters.com - 29.03.2017 (PDF • April 06, 2017)

Clarification on news article - 03.03.2017 (PDF • April 06, 2017)

Notice of AGM to be held on 05.05.2017 (PDF • April 06, 2017)

Appointment of Statutory Auditors - 27.02.2017 (PDF • February 27, 2017)

Outcome of Boad Meeting - Dividend,AGM,Book closure - 27.02.2017 (PDF • February 27, 2017)

Change in Directors - 27.02.2017 (PDF • February 27, 2017)

Authorized officials for disclosure of Material information to stock exchange (PDF • January 04, 2017)

2016

STOCK EXCHANGE ANNOUNCEMENT AND DISCLOSURES 2016

Sanofi India collaborates with National Institute of Pharmaceutical Education and Research (NIPER) Kolkata, to promote academic excellence and research (PDF • November 17, 2016)

SIL -Letter to Stock Exchanges – Change in Company Secretary, Compliance Officer and Key Managerial Personnel - 07.11.2016 (PDF • November 07, 2016)

SIL-Letter to Stock Exchanges- Record Date- Interim Dividend for y.e.31.12.2016 (PDF • July 22, 2016)

Outcome of Board Meeting - 02.06.2016 (PDF • June 02, 2016)

Chairman of the Board of Directors - 02.06.2016 (PDF • June 02, 2016)

SIL-Press Release- Chairman of the Board of Directors 02.06.2016 (PDF • June 02, 2016)

Company statement on the recall of Combiflam batches - 23.05.2016 (PDF • May 23, 2016)

Clarifications on news article Combiflam - 12.05.2016 (PDF • May 12, 2016)

Clarification on appointment of Alternate Directors - 03.05.2016 (PDF • May 03, 2016)

Draft Articles of Association proposed for adoption at AGM 29.04.2016 (PDF • April 29, 2016)

Closure of Register of Members - Final Dividend 2015 - 23.03.2016 (PDF • March 29, 2016)

Letter to the Stock Exchanges- Press Release dated 23rd March 2016 (PDF • March 23, 2016)

Manufacture and sale of fixed dose combinations - 23.03.2016 (PDF • March 23, 2016)

Outcome of Board Meeting held - 23.03.2016 (PDF • March 23, 2016)

2015

STOCK EXCHANGE ANNOUNCEMENT AND DISCLOSURES 2015

Clarification on news item appearing in "Business Standard" - 11.12.2015 (PDF • 2015-12-11)

Re-appointment of Dr. Shailesh Ayyangar as Managing Director - 20.10.2015 (PDF • 2015-10-20)

Appointment of Alternate Directors - 20.10.2015 (PDF • 2015-10-20)

Appointment of Chief Financial Officer - 23.07.2015 (PDF • 2015-07-23)

Changes in Board of Directors - 23.07.2015 (PDF • 2015-07-23)

Interim Dividend for year ending 31st December 2015 - 21.07.2015 (PDF • 2015-07-21)

Sale of building owned by the Company in Andheri, Mumbai 21.07.2015 (PDF • 2015-07-21)

Report on order of CCI - 08.06.2015 (PDF • 2015-06-08)

Notice of Change of Registered Office - 30.03.2015 (PDF • 2015-03-30)